Read More

For more than 40 years, AUTM has provided essential education for technology transfer professionals around the world. The annual AUTM event continues to serve as the single most important meeting place for industry leaders, investors, and academic research professionals. Read More

Few people can start a buzz quite like Elon Musk. Even his cars get people to stop and stare as they drive down the street. Me? I actually offered a guy at my gym money if he’d let me drive his Model S around the block. (He declined. Turns out if you spend $70,000 on a car, you’re not willing to... Read More

Pfizer and the NIH have taken sides on who owns background intellectual property (IP) rights to the blockbuster arthritis drug Xeljanz. Its undisputed that Pfizer invested over $1B in the drug, and its undisputed that Pfizer and NIH had an joint R&D contract, called a CRADA, in place during the... Read More